Effect of Korean Red Ginseng on Oxidation in Middle-aged and Elderly Sub-health Population

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

900

Participants

Timeline

Start Date

March 1, 2023

Primary Completion Date

October 30, 2024

Study Completion Date

December 10, 2024

Conditions
Healthy AgeingAntioxidative Stress
Interventions
DRUG

Korean red ginseng capsule (marketed product in Korea)

Korean red ginseng capsule (marketed product in Korea) KRGO group and placebo group were used for treatment. The random number is generated by the central randomization system. All the recruiters were divided into placebo group and KRGO group. The numbers will be assigned according to random numbers. In this study, qualified subjects were randomly assigned to the KRGO group and placebo group at a ratio of 1:1. The drug was administered for 12 weeks, 2 times a day, 3 capsules each time.

DRUG

Korean red ginseng capsule(placebo)

"KRGO group and placebo group were used for treatment. The random number is generated by the central randomization system. All the recruiters were divided into placebo group and KRGO group.~The numbers will be assigned according to random numbers. In this study, qualified subjects were randomly assigned to the KRGO group and placebo group at a ratio of 1:1. The drug was administered for 12 weeks, 2 times a day, 3 capsules each time."

Trial Locations (4)

100026

Beijing Obstetrics and Gynecology Hospital Affiliated to Capital Medical University, Beijing

200127

Renji Hospital Affiliated to Shanghai Jiaotong University, Shanghai

330006

Nanchang Hongdu Hospital of TCM, Nanchang

528031

Foshan Fuxing Changcheng Hospital, Foshan

All Listed Sponsors
collaborator

RenJi Hospital

OTHER

collaborator

Beijing Obstetrics and Gynecology Hospital

OTHER

collaborator

Foshan Fuxing Changcheng Hospital

UNKNOWN

collaborator

Nanchang Hongdu Hospital of TCM

UNKNOWN

lead

Shanghai Jiao Tong University School of Medicine

OTHER